Chronic subdural hematoma (CSDH) is a frequent condition in neurosurgery, leading to fluid accumulation between the meninges, brain compression, neurological dysfunction, and potentially herniation. The efficacy of treatments and their long-term outcomes remain uncertain, with no established standard. Notably, neuroendoscopy-assisted hematoma evacuation, in contrast to burr-hole drainage, enables direct visualization and thorough removal of the hematoma, thereby minimizing residue, lowering recurrence rates, and shortening drainage duration. This study will undertake a multicenter trial to compare these two methods and determine the superior treatment approach for CSDH.
Patient (18 years to 90 years) presenting with clinical symptoms and neurological deficits of CSDH.
CSDH verified on cranial computed tomography or magnetic resonance imaging.
Written informed consent from patients or their next of kin according to the patient's cognitive status.
No clinical symptoms correlating with chronic subdural hematoma.
Lack of mass effect and midline shift < 5 mm on the radiological image, or no need surgery judged clinically by neurosurgeons.
Previous surgery for CSDH during the past 6 months.
Previous intracranial surgery for any other neurological disorder.